Photosynthesis will not occur. The cell will lose its shape and support. Cellular respiration will not take place. Substances will not move in and out of the cell.
La respuesta es:
RE. Una suposición fundamentada de la respuesta a una pregunta
The physiologic factors that affect motility of food in the stomach and small intestines is :
- The abnormalities in the muscle.
<h3>What
cause stomach motility?</h3>
Genes are known to often play a role in in some cases of gastric motility disorders and it is seen in Hirschsprung's disease, intestinal pseudo-obstruction, and others.
Note that Weak contractions of the small intestine are as a result of the to issues in the muscle and are known to be linked or associated with diseases e.g. scleroderma.
Note that connective tissue disorders can lead or cause damage to the intestine and as such, the physiologic factors that affect motility of food in the stomach and small intestines is the abnormalities in the muscle.
Learn more about stomach motility from
brainly.com/question/2738815
#SPJ1
Answer:n Québec, indigenous activists' most poignant and effective resistance methods were testimonials of the collective violence that policies like NAFTA perpetrate ...
Explanation:
Answer:
In this study, we tested the effects of NEAA-deprived diets and checkpoint inhibitor anti-PD-1 and anti-PD-L1 in colon cancer using syngeneic mouse model (Balb/c) bearing tumors of mouse colorectal cancer cell line CT-26. Three diets were tested, including a natural rodent diet Teklad ENVIGO Global 16% Protein Rodent Diet (control 1), a formulated NEAA-complete diet COMPLETE (control 2, using amino acid mix in place of protein), and a formulated NEAA-deprived diet FTN203 (treatment, using amino acid mix in place of protein). Both COMPLETE and FTN203 have the same nutritional structures, contain 17% w/w protein equivalent, and are isocaloric. After tumor size-based randomization, these diets were provided to mice ad libitum throughout the whole test. Each of these diets was used alone or combined with anti-PD-1 antibody (i.p., twice per week for 2 weeks) or anti-PD-L1 antibody (i.v., twice per week for 2 weeks).
Explanation:
